Tu’uhevaha Kaitu’u-LinoBBiomedSci (hons), PhD. Associate Professor at the University of Melbourne
Laboratory studies to identify new biomarkers for Preeclampsia and to study the pathogenesis of the disease
Tu’uhevaha is head of the Diagnostics Discovery and Reverse Translation Group at the University of Melbourne and Mercy Perinatal. She is working to identify novel biomarkers to predict which women are at risk of serious pregnancy complications such as preeclampsia and fetal growth restriction. She then uses the data gained from her biomarker studies to study the pathogenesis of these diseases, with the aim of identifying new therapeutic targets.
Tu’uhevaha is a co-investigator on the PI2 study and working in collaboration with Cathy Cluver, Lina Bergman and Roxanne Hastie to measure novel biomarkers in the PROVE study.